- Filed
- May 3, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Apr 19, 2024 | 258.15M sh |
| Shares Diluted | Q2 2024 · Mar 31, 2024 | 259.3M sh |
| Shares Diluted | Q2 2024 · Mar 31, 2024 | 257.5M sh |
| Shares Diluted | Q2 2024 · Mar 31, 2023 | 255.6M sh |
| Shares Diluted | Q2 2024 · Mar 31, 2023 | 255.2M sh |
| Dividends Paid | Q2 2024 · Mar 31, 2024 | $155.6M |
| Dividends Paid | Q2 2024 · Mar 31, 2023 | $140.3M |
| Capex | Q2 2024 · Mar 31, 2024 | $548.6M |
| Capex | Q2 2024 · Mar 31, 2023 | $563.7M |
| Operating Cash Flow | Q2 2024 · Mar 31, 2024 | $312.1M |
| Operating Cash Flow | Q2 2024 · Mar 31, 2023 | $550M |
| Long Term Debt | Q2 2024 · Mar 31, 2024 | $7.72B |
| Long Term Debt | Q2 2024 · Sep 30, 2023 | $8.05B |
| Short Term Debt | Q2 2024 · Mar 31, 2024 | $1.32B |
| Short Term Debt | Q2 2024 · Sep 30, 2023 | $533M |
| Cash And Equivalents | Q2 2024 · Mar 31, 2024 | $494.7M |
| Cash And Equivalents | Q2 2024 · Sep 30, 2023 | $393.4M |
| Stockholders Equity | Q2 2024 · Mar 31, 2024 | $10.07B |
| Stockholders Equity | Q2 2024 · Sep 30, 2023 | $10.08B |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $9.64B |
| Current Liabilities | Q2 2024 · Mar 31, 2024 | $4.74B |
| Current Liabilities | Q2 2024 · Sep 30, 2023 | $4.92B |
| Current Assets | Q2 2024 · Mar 31, 2024 | $6.34B |
| Current Assets | Q2 2024 · Sep 30, 2023 | $6.99B |
| Total Assets | Q2 2024 · Mar 31, 2024 | $26.88B |
| Total Assets | Q2 2024 · Sep 30, 2023 | $27.44B |
| Eps Diluted | Q2 2024 · Mar 31, 2024 | $0.06 |
| Eps Diluted | Q2 2024 · Mar 31, 2024 | −$0.03 |
| Eps Diluted | Q2 2024 · Mar 31, 2023 | −$7.85 |
| Eps Diluted | Q2 2024 · Mar 31, 2023 | −$7.68 |
| Eps Basic | Q2 2024 · Mar 31, 2024 | $0.06 |
| Eps Basic | Q2 2024 · Mar 31, 2024 | −$0.03 |
| Eps Basic | Q2 2024 · Mar 31, 2023 | −$7.85 |
| Eps Basic | Q2 2024 · Mar 31, 2023 | −$7.68 |
| Net Income | Q2 2024 · Mar 31, 2024 | $15.5M |
| Net Income | Q2 2024 · Mar 31, 2024 | −$6.9M |
| Net Income | Q2 2024 · Mar 31, 2023 | −$2.01B |
| Net Income | Q2 2024 · Mar 31, 2023 | −$1.96B |
| Operating Income | Q2 2024 · Mar 31, 2024 | $120.4M |
| Operating Income | Q2 2024 · Mar 31, 2024 | $204.6M |
| Operating Income | Q2 2024 · Mar 31, 2023 | −$1.99B |
| Operating Income | Q2 2024 · Mar 31, 2023 | −$1.83B |
| Gross Profit | Q2 2024 · Mar 31, 2024 | $780.1M |
| Gross Profit | Q2 2024 · Mar 31, 2024 | $1.54B |
| Gross Profit restated | Q2 2024 · Mar 31, 2023 | $920M |
| Gross Profit restated | Q2 2024 · Mar 31, 2023 | $1.69B |
| Cost Of Revenue | Q2 2024 · Mar 31, 2024 | $3.95B |
| Cost Of Revenue | Q2 2024 · Mar 31, 2024 | $7.81B |
| Cost Of Revenue restated | Q2 2024 · Mar 31, 2023 | $4.36B |
| Cost Of Revenue restated | Q2 2024 · Mar 31, 2023 | $8.51B |
| Revenue | Q2 2024 · Mar 31, 2024 | $4.73B |
| Revenue | Q2 2024 · Mar 31, 2024 | $9.35B |
| Revenue | Q2 2024 · Mar 31, 2023 | $5.28B |
| Revenue | Q2 2024 · Mar 31, 2023 | $10.2B |